Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 3, 2013, Pages 289-296

  Vlagea, Alexandru ^a   Gil, Antonio ^a   Cuesta, Maria V ^a   Arribas, Florencia ^a   Diez, Jesús ^a   Lavilla, Paz ^a   Pascual Salcedo, Dora ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

clinical thrombophilia; deep venous thrombosis; pulmonary embolism; recurrent abortion; stroke; thrombosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HUMAN; KIDNEY ARTERY EMBOLISM; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CLINICAL THROMBOPHILIA; DEEP VENOUS THROMBOSIS; PULMONARY EMBOLISM; RECURRENT ABORTION; STROKE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PROTHROMBIN;

EID: 84878867111     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612437578     Document Type: Article

References (27)

1. Thomas RH. Hypercoagulability syndromes. Arch Intern Med. 2001 ; 161 ((20)). 2433-2439
2. Amengual O, Atsumi T, Koike T. Antiprothrombin antibodies and the diagnosis of antiphospholipid syndrome. Clin Immunol. 2004 ; 112 ((2)). 144-149
3. Oku K, Atsumi T, Amengual O, Koike T. Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Hemost. 2008 ; 34 ((4)). 335-339
4. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4 ((2)). 295-306
5. Galli M. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?. J Autoimmun. 2000 ; 15 ((2)). 101-105
6. Amengual O, Atsumi T, Koike T. Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis Rheum. 2003 ; 48 ((4)). 886-895
7. Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003 ; 102 ((8)). 2717-2723
8. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulant. Thromb Haemost. 1995 ; 74 ((4)). 1120-1125
9. Matsuda J, Saitoh M, Gotoh M, Kawasugi K, Gohchi K, Tsukamoto M. Phosphatidyl serine-dependent Antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol. 1996 ; 35 ((6)). 589-591
10. Matsuda J, Sanaka T, Nishizawa A, Gotoh M, Gohchi K. Two antiprothrombin antibodies against prothrombin and prothrombin-phosphatidyl serine show partial but not total identity. Blood Coagul Fibrinolysis. 2002 ; 13 ((8)). 697-702
11. Sakai Y, Atsumi T, Ieko M, et al. The effects of Phosphatidylserine- dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum. 2009 ; 60 ((8)). 2457-2467
12. Atsumi T, Ieko M, Bertolaccini ML, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 2000 ; 43 ((9)). 1982-1993
13. Brant J, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: an update. On behalf of the subcommittee on Lupus Anticoagulant/antiphospholipid antibody of the scientific and standardization committee of the ISTH. Thromb Haemost. 1995 ; 74 ((4)). 1185-1190
14. Nojima J, Kuratsune H, Suehisa E, et al. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haematol. 2001 ; 114 ((3)). 647-654
15. Bertolaccini ML, Atsumi T, Koike T, Hughes GRV, Khamashta MA. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Hemost. 2005 ; 93 ((2)). 289-297
16. Tsutsumi A, Hayashi T, Chino Y, et al. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol. 2006 ; 16 ((3)). 158-164
17. Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies. Thromb Haemost. 2004 ; 91 ((967)). 976
18. Nojima J, Yoshinori I, Suehisa E, Kuratsune H, Kanakura Y. The presence of anti-phosphatidylserine/prothrombin antibodies as a risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica. 2006 ; 91 ((5)). 699-702
19. Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thrombembolism. Clin Chem. 2005 ; 51 ((3)). 545-552
20. Ieko M, Nakabayashi T, Turumi T, et al. Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome. Rinsho Byori. 2006 ; 54 ((3)). 256-262
21. Atsumi T, Amengual O, Yasuda S, Koike T. Antiprothrombin antibodies - are they worth assaying?. Thromb Res. 2004 ; 114 ((5-6)). 533-538
22. Bertolaccini ML, Gómez S, Pareja JFP, et al. Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis. 2005 ; 64 ((11)). 1639-1643
23. Yamada H, Atsumi T, Kato EH, Shimada S, Morikawa M, Minakami H. Prevalence of diverse antiphospholipid antibodies in women with recurrent spontaneous abortion. Fertil Steril. 2003 ; 80 ((5)). 1276-1278
24. Yamada H, Atsumi T, Kobashi G, et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol. 2009 ; 79 ((2)). 188-195
25. Tsutsumi A, Atsumi T, Yamada H, et al. Anti-phosphatidylserine/ prothrombin antibodies are not frequently found in patients with unexplained recurrent miscarriages. Am J Reprod Immunol. 2001 ; 46 ((3)). 242-244
26. Atsumi T, Koike T. Antiprothrombin antibody: why do we need more assays?. Lupus. 2010 ; 19 ((4)). 436-439
27. Bertolaccini ML, Amengual O, Atsumi T, et al. "Non-criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus. 2011 ; 20: 191